Filtering by:
Cervical CancerResearch to Help Boost Cancer Prevention in Countryside Teens
Only about 30% of adolescents who live in rural Oregon are up to date with the HPV vaccine. Learn how the RAVE Study is helping uncover vaccine barriers & solutions.
Cervical Precancers Drop Since Introduction of HPV Vaccine
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer – lesions that can become cervical cancer.
Slideshow: 9 Key Findings from ACS Researchers’ Study of Cancer in People Ages 15 to 39
Cancers in adolescents and young adults (AYAs)—in ages 15 to 39—are the focus of a new report published in CA: A Cancer Journal for Clinicians on September 17, 2020. The researchers looked at rates and trends by sex and race/ethnicity, across 3 smaller age groups: Ages 15 to 19 (referred to as adolescents or teens), ages 20 to 29, and ages 30 to 39.
ACS Updates Cervical Cancer Screening Guidelines to Start Screening at Age 25
The American Cancer Society (ACS) has updated its screening guideline for cervical cancer. The new guideline is for people with a cervix with an average risk of cervical cancer.
ACS Updates HPV Vaccination Recommendations to Start at Age 9
The American Cancer Society (ACS) has updated its guideline for human papilloma virus (HPV) vaccination. New recommendations are for healthcare providers to routinely offer the HPV vaccine series to boys and girls between ages 9 and 12.
Cervical Cancer Survivor Relies on a Plan
When Coral Conway was diagnosed with stage IIIB cervical cancer, she felt overwhelmed. She was getting advice and information from many different sources. She had visited local doctors and hospitals in Florida and talked with professionals in her home country of Argentina.
Year in Review: Cancer Research Insights from 2018
Read highlights about American Cancer Society research from 2018.
Studies Find Open Surgery Safer For Early Cervical Cancer
Researchers at the University of Texas MD Anderson Cancer Center and colleagues find that women who undergo minimally invasive radical hysterectomy to treat early-stage cervical cancer have worse outcomes than women who undergo abdominal “open” radical hysterectomy.